CENTRIENT

LIVE

Serial Number

79260200

Owner

Centrient Pharmaceuticals Netherlands B.V.

Attorney

Susan Natland

Filing Date

Apr 10, 2019

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

CENTRIENT Trademark

Serial Number: 79260200 • Registration: 5952450

CENTRIENT is a trademark filed by Centrient Pharmaceuticals Netherlands B.V. on April 10, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 1 - Chemicals

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Centrient Pharmaceuticals Netherlands B.V. (12 trademarks)

Alexander Fleminglaan 1

Entity Type: 98

Legal Representation

Attorney of Record

Susan Natland

1,205 trademarks filed View all →

Correspondence Address

Susan Natland Baker & Hostetler LLP

600 Anton Blvd., Suite 900

Costa Mesa, CA 92626

United States

Trademark Details

Filing Date

April 10, 2019

Registration Date

January 7, 2020

Published for Opposition

October 22, 2019

Goods & Services

Chemical ingredients for pharmaceutical preparations and for pharmaceutical use, especially ingredients for the manufacture of antibiotics, statins and antifungals

Active pharmaceutical ingredients, namely preparations for the manufacture of antibiotics, statins and antifungals

Filing History

TEAS SECTION 71 & 15 RECEIVED

Dec 31, 2025 ES75

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Jan 7, 2025 REM3

FINAL DECISION TRANSACTION PROCESSED BY IB

Jul 17, 2020 FINO

GENERIC MADRID TRANSACTION SENT TO IB

Apr 20, 2020 XXSS

GENERIC MADRID TRANSACTION CREATED

Apr 20, 2020 XXCR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Apr 7, 2020 FICR

CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED

Mar 23, 2020 CORN

CORRECTION TRANSACTION RECEIVED FROM IB

Mar 20, 2020 CRCV

REGISTERED-PRINCIPAL REGISTER

Jan 7, 2020 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 22, 2019 NPUB

PUBLISHED FOR OPPOSITION

Oct 22, 2019 PUBO

NOTIFICATION PROCESSED BY IB

Oct 19, 2019 GPNX

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Oct 2, 2019 OPNS

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Oct 2, 2019 OP2R

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 2, 2019 NONP

ASSIGNED TO LIE

Sep 18, 2019 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 16, 2019 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 16, 2019 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 15, 2019 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 15, 2019 TROA

REFUSAL PROCESSED BY IB

Aug 2, 2019 RFNT

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jul 12, 2019 RFCS

REFUSAL PROCESSED BY MPU

Jul 12, 2019 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Jun 20, 2019 RFCR

NON-FINAL ACTION WRITTEN

Jun 19, 2019 CNRT

ASSIGNED TO EXAMINER

Jun 19, 2019 DOCK

APPLICATION FILING RECEIPT MAILED

Jun 14, 2019 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 10, 2019 NWOS

SN ASSIGNED FOR SECT 66A APPL FROM IB

Jun 6, 2019 REPR

Related Trademarks

More from this Owner

C CENTRIENT

PURIDROX

PUREACTIVES

More in Same Class

DARLING INGREDIENTS INC.

HUSY

SKINEODERM

REALTECH

VASCULAR TISSUE BLANKS

Serial #88379323